In the US, Nabilone (nabilone systemic) is a member of the drug class miscellaneous antiemetics and is used to treat Nausea/Vomiting, Chemotherapy Induced.
US matches:
- Nabilone
UK matches:
- Nabilone 1mg Capsules
- Nabilone 1mg Capsules (SPC)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
A04AD11
CAS registry number (Chemical Abstracts Service)
0051022-71-0
Chemical Formula
C24-H36-O3
Molecular Weight
372
Therapeutic Category
Antiemetic
Chemical Names
trans-(±)-3-(1,1-Dimethylheptyl)-6,6abeta,7,8,10,10aα-hexahydro-1-hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one
(±)-trans-3-(1,1-Dimethylheptyl)-1-hydroxy-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-on (IUPAC)
(±)-trans-3-(1,1-Dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one (WHO)
(±)-(6aR,10aR)-3-(1,1-Dimethylheptyl)-6a,7,8,10,10a-hexahydro-1-hydroxy-6,6-dimethyl-6H-benzo[c] chromen-9-one (BAN)
(±)-3-(1,1-Dimethylheptyl)-6,6abeta,7,8,10,10aα-hexahydro-1-hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one (USAN)
(6aR,10aR)-rel-3-(1,1-Dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one
(6aRS,10aRS)-1-Hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-6,6a,7,8,10,10a-hexahydro-9H-benzo[c]chromen-9-on
9H-Dibenzo[b,d]pyran-9-one, 3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,6-dimethyl-, trans-(±)- (USAN)
Foreign Names
- Nabilonum (Latin)
- Nabilon (German)
- Nabilone (French)
- Nabilona (Spanish)
Generic Names
- Nabilone (OS: BAN, USAN)
- Cpd 109514 (IS: Lilly)
- LY 109 514 (IS: Lilly)
Brand Names
- Cesamet
Meda, United States; Valeant, Argentina; Valeant, Canada
International Drug Name Search
Glossary
| BAN | British Approved Name |
| IUPAC | International Union of Pure and Applied Chemistry |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| SPC | Summary of Product Characteristics (UK) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment